MarketsandMarkets Conferences (MnM Conferences) is delighted to announce the inaugural Cancer Diagnosis & Therapy Congress to be held on September 3-4, 2015 London, UK focusing on the theme of “Advancement in Cancer diagnosis, treatment and challenges in organ specific cancer treatment”.
The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research.
Despite significant progress cancer still has one of the highest mortality rates with 14 million new cases and 8.2 million deaths in 2012 and this figure is expected to rise by approximately 70% in coming two decades worldwide as reported by the IARC-WHO. Also it is reported that in Europe alone 1,32,3600 cancer deaths are predicted by end of 2014.
Currently the cancer market has reached $100 billion with 5% a compound annual growth rate (CAGR) annually in targeted therapy markets alone. However it has become clear that the global battle against cancer won’t be conquered with treatment alone and that effective prevention, measures and awareness. Bringing together 150 + experts from industry, research laboratories, hospitals, device and diagnostic manufacturers and academia in the arena of cancer research, the Cancer Therapy and Diagnosis Congress will provide an international platform to meet and network with experts from around the globe through scientific and industry oriented sessions, panel discussions, symposiums, workshops and vibrant exhibition area.
• Advanced Cancer Detection, Diagnosis Methods and Technologies
• Novel Approaches to Cancer Therapy
• Emerging Challenges in Organ Specific Cancers Research
For more information visit our website. To register for the conference click here.